Abstract
Ion channels are integral membrane proteins that enable the passive flow of inorganic ions by forming hydrated pores across biological membranes. Their pore-forming alpha subunits determine ion permeation and provide the machinery for gating. In addition, channel class specific accessory proteins termed beta, gamma and delta subunits have been found that modulate or even determine key properties like channel gating (e.g. activation, inactivation properties), surface expression, targeting and stability. Moreover, some of these subunits constitute binding sites for toxins as well as for therapeutic drugs. With the development of more powerful proteomic and molecular biology-based methods, a vastly increasing number of proteins interacting with ion channels has recently been described. These results are providing novel insight into ion channel function and at the same time challenging classical concepts of beta subunits and ion channel drug targets. They are also raising questions about functional validation and reliability of these methods. This review focuses on the potentials and limitations of modern “-omic” protein-protein interaction analyses and their application to ion channels. After recapitulating fundamental thermodynamic and biochemical principles underlying protein-protein interactions, current methods for their systematic identification are critically reviewed. Selected examples of newly characterized ion channel complexes will then be discussed to illustrate the implications for molecular understanding as well as for the effective selection and screening of ion channel drug targets.
CNS & Neurological Disorders - Drug Targets
Title: Protein-Protein Interactions and Subunit Composition of Ion Channels
Volume: 7 Issue: 2
Author(s): Uwe Schulte
Affiliation:
Abstract: Ion channels are integral membrane proteins that enable the passive flow of inorganic ions by forming hydrated pores across biological membranes. Their pore-forming alpha subunits determine ion permeation and provide the machinery for gating. In addition, channel class specific accessory proteins termed beta, gamma and delta subunits have been found that modulate or even determine key properties like channel gating (e.g. activation, inactivation properties), surface expression, targeting and stability. Moreover, some of these subunits constitute binding sites for toxins as well as for therapeutic drugs. With the development of more powerful proteomic and molecular biology-based methods, a vastly increasing number of proteins interacting with ion channels has recently been described. These results are providing novel insight into ion channel function and at the same time challenging classical concepts of beta subunits and ion channel drug targets. They are also raising questions about functional validation and reliability of these methods. This review focuses on the potentials and limitations of modern “-omic” protein-protein interaction analyses and their application to ion channels. After recapitulating fundamental thermodynamic and biochemical principles underlying protein-protein interactions, current methods for their systematic identification are critically reviewed. Selected examples of newly characterized ion channel complexes will then be discussed to illustrate the implications for molecular understanding as well as for the effective selection and screening of ion channel drug targets.
Export Options
About this article
Cite this article as:
Schulte Uwe, Protein-Protein Interactions and Subunit Composition of Ion Channels, CNS & Neurological Disorders - Drug Targets 2008; 7 (2) . https://dx.doi.org/10.2174/187152708784083795
DOI https://dx.doi.org/10.2174/187152708784083795 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Challenge of microRNA as a Biomarker of Epilepsy
Current Neuropharmacology A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine
Current Pharmaceutical Design Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases
Current Topics in Medicinal Chemistry Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency
Current Alzheimer Research Synthesis, Anticonvulsant and Neurotoxicity Evaluation of Some Newer N-(2-benzoylbenzofuran-3-yl)-3-(substituted)-propanamide Analogs
Central Nervous System Agents in Medicinal Chemistry The Potential Clinical Properties of Magnesium
Current Medicinal Chemistry Antiepileptic Drugs for Preventing Seizures in Patients with Chronic Subdural Hematoma
Current Pharmaceutical Design NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target
Current Drug Targets Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Substituted Aminobenzothiazole Derivatives of Tacrine: Synthesis and Study on Learning and Memory Impairment in Scopolamine-Induced Model of Amnesia in Rat
Mini-Reviews in Medicinal Chemistry Cannabinoids
Current Drug Targets - CNS & Neurological Disorders Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Current Pharmaceutical Design The Role of Innate Immune System Receptors in Epilepsy Research
CNS & Neurological Disorders - Drug Targets Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Current Psychopharmacology A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects
Current Drug Abuse Reviews Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
Current Neuropharmacology Effect of the Surfactant and Liquid Lipid Type in the Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin
Pharmaceutical Nanotechnology